Full Text View
Tabular View
No Study Results Posted
Related Studies
Cross-over Study to Prove Bioequivalence Between Two Brands of Cefalexin Capsules
This study has been completed.
Study NCT01073553   Information provided by Bayer

First Received on February 22, 2010.   Last Updated on April 9, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anti-Infective Agents
Interventions listed in this trial
Cephalexin capsules (Keflex)
Additional drug interventions recognized in this trial
Cephalexin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Bayer
Corporación Bonima S.A. de C.V.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services